Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples